CIS football athlete, Quinn Smith, suspended for the presence of Stanozolol

June 3, 2014 – The Canadian Centre for Ethics in Sport (CCES) confirmed today that Quinn Smith, a Canadian Interuniversity Sport (CIS) football player, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on March 21, 2014, revealed the presence of stanozolol, a prohibited anabolic agent.
In response to the CCES’ notification of the adverse analytical finding, Mr. Smith waived his right to a hearing, admitted to the anti-doping rule violation, and accepted a two-year sanction ending March 21, 2016. The athlete, who resides in Scarborough, Ontario, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.



Related Articles